Transcriptomics News and Research

RSS

New workflow tracks lipid changes in oil-producing yeast species

A research team led by Profs. XU Guowang and LIU Xinyu from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences (CAS), in collaboration with researchers from Dalian University of Technology, has developed a high-coverage lipidomics workflow and integrated it with transcriptomics to investigate lipid accumulation and compositional changes in Rhodosporidium toruloides under nitrogen limitation.

4 Nov 2026

MGI Tech partners with Parque Científico de Madrid to expand access to Stereo-seq in Spain

PCM's new STOmics certification enables cutting-edge spatial transcriptomics, fostering collaboration in genomics and enhancing research capabilities in Spain.

From MGI 4 Nov 2026

Spatial study maps active epithelial crosstalk driving chronic periodontitis

Epithelial barriers are active organizers of tissue homeostasis, immune surveillance and host defense, yet chronic inflammation can corrupt their repair and communication with connective tissue.

2 Nov 2026

Skin organoids reveal how herpes simplex virus spreads between cells

Researchers at the Max Delbrück Center and University Medical Center Hamburg-Eppendorf have traced in skin organoids, how herpes simplex virus 1 infection progresses among neighboring skin cells, deepening our understanding.

30 Oct 2026

Space-grown organoids better replicate aggressive glioblastoma tumors

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and is one of the most aggressive and deadly forms of cancer.

30 Oct 2026

Premature infants show altered cerebellum growth and developmental trajectories

A new study reveals that when a baby is born prematurely, their cerebellum, the part of the brain with a critical role in motor function, language and cognition, grows and develops in a different way than it would if the baby remains in utero full term.

29 Oct 2026

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Discover how omics is transforming life sciences with expert insights from Dr. Shi-Qi An on multiomics, single-cell research and drug discovery.

23 Oct 2026

Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and SPT Labtech today announced their partnership to deliver validated, automated library preparation workflows that combine Takara Bio next-generation sequencing (NGS) library preparation chemistries with SPT Labtech's firefly liquid handling platform.

From Takara Bio USA, Inc. 21 Oct 2026

Targeting the RUNX1 gene helps reduce severe skin fibrosis

Skin fibrosis includes hypertrophic scar (HTS), keloid scar (KS), and systemic sclerosis (SSc). These conditions share persistent fibroblast activation, excessive extracellular matrix (ECM) deposition, and progressive skin remodeling.

13 Oct 2026

Single-cell analysis reveals how pancreatic cancer evades treatment

An analysis of nearly half a million cells from dozens of patients' tumors reveals how cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment for one of the deadliest forms of cancer.

13 Oct 2026

Study reveals how different plant saponins alleviate ischemic stroke

Ischemic stroke accounts for approximately 85% of all strokes and remains a major cause of death and long-term disability.

12 Oct 2026

Scientists identify the neuroblastoma cells that signal poor outcomes

Neuroblastoma is the most common solid tumor found outside of the brain in children, yet why some children respond well to treatment while others do not has remained poorly understood.

10 Oct 2026

Study identifies spatial niche as key to gastric cancer initiation

Early gastric cancer (EGC) represents the most critical yet biologically least understood stage in gastric carcinogenesis.

6 Oct 2026

Spatial mapping reveals macrophage niches linked to severe COVID-19 lung injury

Researchers at the University of Liège have used imaging-based spatial single-cell transcriptomics to map the cellular organization of lungs from people who died with severe COVID-19.

1 Oct 2026

UC San Diego receives funding to establish the Polysubstance Addiction Research Center

Researchers from University of California San Diego have received a $12.6 million award from the National Institute on Drug Abuse (NIDA) to establish the Polysubstance Addiction Research Center (PARC), a multidisciplinary center designed to uncover the biological factors that contribute to addiction across multiple substances.

30 Sep 2026

Study identifies three cell clusters driving pancreatic cancer-induced cachexia

Research published today in Cell identifies three small subclusters of cells driving pancreatic cancer-induced cachexia, a muscle-wasting and fat-loss condition that makes patients less tolerant of cancer treatment.

29 Sep 2026

An AI-identified biomarker can look accurate and still fail its biggest test

The review examines how AI combines molecular, imaging, circulating, cellular, and digital data to identify potential disease biomarkers. Its authors argue that independent validation, biological testing, and evidence of better clinical decisions are needed before those candidates enter patient care.

28 Sep 2026

Specialized immune cells bridge the nervous and immune systems

A collaborative team led by Professor Jie Zhou at Tianjin Medical University School of Basic Medicine and Professor Qiang Liu at Tianjin Medical University General Hospital published a comprehensive review in Volume 2 of the journal Immunity & Inflammation on September 8, 2026.

25 Sep 2026

Mount Sinai researchers discover how Alzheimer's gene damages blood vessels

Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the buildup of abnormal proteins linked to neurodegenerative disease.

24 Sep 2026

PsychAD studies map molecular mechanisms across major brain disorders

Research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative launched in 2019 with support from the National Institute on Aging (NIA), is featured in a landmark collection of nine papers published across the Nature family of journals that maps the molecular mechanisms underlying Alzheimer's disease, Parkinson's disease, schizophrenia, and other brain disorders.

23 Sep 2026